Arrowhead Pharmaceuticals, Inc. logo ARWR - Arrowhead Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 15
HOLD 5
SELL 0
STRONG
SELL 0
| PRICE TARGET: $83.56 DETAILS
HIGH: $110.00
LOW: $35.00
MEDIAN: $90.00
CONSENSUS: $83.56
UPSIDE: 11.49%

Profitability Ratios

Ratio Value
GP Margin 100.0%
EBIT Margin 17.0%
EBITDA Margin 19.9%
Operating Margin 11.9%
Pretax Margin 6.2%
Cont. Ops Margin 3.6%
Net Margin -0.2%
Bottom Line Margin -0.2%

Liquidity Ratios

Ratio Value
Current Ratio 4.86
Quick Ratio 4.86
Solvency Ratio 0.025
Cash Ratio 1.16

Valuation Ratios

Ratio Value
Price/Earnings
-2828.52
Hist. avg: 38.9
Peers avg: 34.5
PEG Ratio 28.35
Forward PEG 28.35
Price/Book 9.90
Price/Sales 5.56
Price/FCF 29.41
Price/Op Cash Flow 25.69

Debt Ratios

Ratio Value
Debt/Assets 0.2644
Debt/Equity 0.7859
Debt/Capital 0.4401
Long-Term Debt/Capital 0.3156
Financial Leverage 2.97

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.23
Operating Cash Flow Ratio 0.918
Operating Cash Flow/Sales 21.6%
Free Cash Flow/Operating Cash Flow 87.4%

Coverage Ratios

Ratio Value
Debt Service Coverage 1.11
Interest Coverage 1.1005
Short-Term Operating Cash Flow Coverage 4.49
Operating Cash Flow Coverage 0.49
Capital Expenditure Coverage 7.92
Dividend + Capital Expenditure Coverage 7.92

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 6.20
EPS -0.012
Debt/Share 3.4065
Cash/Share 6.87
Book Value/Share 3.76
Tangible BV/Share 3.71
Equity/Share 3.48
Operating Cash Flow/Share 1.342
Capital Expenditure/Share 0.169
FCF/Share 1.173

Other Ratios

Ratio Value
Net Income/Earnings Before Tax -0.032
Earnings Before Tax/EBIT 0.524
Price/Fair Value 9.90
Debt/Market Cap 0.0552
Effective Tax Rate 41.6%
Enterprise Value Multiple 28.84